PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
PANDY vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

PANDY vs. NVO

Last updated Jun 6, 2026

PANDY (Pandora A/S ADR) and NVO (Novo Nordisk A/S) are both stocks. PANDY operates in Luxury Goods (Consumer Cyclical), while NVO operates in Drug Manufacturers - General (Healthcare).

Performance

PANDY vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pandora A/S ADR (PANDY) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

PANDY

1D
0.00%
1M
0.00%
YTD
—
6M
—
1Y
—
3Y*
—
5Y*
—
10Y*
—

NVO

1D
-1.81%
1M
-6.12%
YTD
-12.61%
6M
-7.10%
1Y
-38.11%
3Y*
-16.73%
5Y*
3.36%
10Y*
6.32%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PANDY vs. NVO - Yearly Performance Comparison

2026 (YTD)
PANDY
Pandora A/S ADR		0.00%
NVO
Novo Nordisk A/S		-6.67%

Fundamentals

Total Revenue (TTM)

PANDY:

$31.68B

NVO:

$327.80B

Gross Profit (TTM)

PANDY:

$25.29B

NVO:

$268.30B

EBITDA (TTM)

PANDY:

$10.08B

NVO:

$181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Pandora A/S ADR

Novo Nordisk A/S

Often compared with PANDY:
PANDY vs. VOO
Often compared with NVO:
NVO vs. LLYNVO vs. NOV.DENVO vs. NVSNVO vs. MRKNVO vs. XLVNVO vs. AZNNVO vs. LLY.DE

Return for Risk

PANDY vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
PANDY
NVO
NVO Risk / Return Rank: 1515
Overall Rank
NVO Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 1414
Sortino Ratio Rank
NVO Omega Ratio Rank: 1313
Omega Ratio Rank
NVO Calmar Ratio Rank: 1616
Calmar Ratio Rank
NVO Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PANDY vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pandora A/S ADR (PANDY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

PANDY vs. NVO - Sharpe Ratio Comparison

Loading charts...

Sharpe Ratios by Period

PANDYNVODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

—

-0.74

—

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

—

0.09

—

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

—

0.19

—

Sharpe Ratio (All Time)

Calculated using the full available price history

—

0.47

—

Drawdowns

PANDY vs. NVO - Drawdown Comparison

The maximum PANDY drawdown since its inception was 0.00%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for PANDY and NVO.

Loading charts...

Drawdown Indicators

PANDYNVODifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-74.70%

+74.70%

Max Drawdown (1Y)

Largest decline over 1 year

—

-55.03%

—

Max Drawdown (3Y)

Largest decline over 3 years

—

-74.70%

—

Max Drawdown (5Y)

Largest decline over 5 years

—

-74.70%

—

Max Drawdown (10Y)

Largest decline over 10 years

—

-74.70%

—

Current Drawdown

Current decline from peak

0.00%

-68.78%

+68.78%

Average Drawdown

Average peak-to-trough decline

0.00%

-17.77%

+17.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

—

37.09%

—

Volatility

PANDY vs. NVO - Volatility Comparison

Loading charts...

Volatility by Period

PANDYNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

—

8.76%

—

Volatility (6M)

Calculated over the trailing 6-month period

—

38.04%

—

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

51.88%

-51.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

38.24%

-38.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

32.52%

-32.52%

Dividends

PANDY vs. NVO - Dividend Comparison

PANDY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.20%.

PositionTTM20252024202320222021202020192018201720162015
NVO
Novo Nordisk A/S		4.20%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
PANDY
Pandora A/S ADR		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PANDY vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Pandora A/S ADR and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
11.97B
96.82B
(PANDY) Total Revenue
(NVO) Total Revenue
Values in USD except per share items
Portfolio Optimizer

Find the right allocation for PANDY and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer